Skip to Main Content

Paper Details

Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.
J Virol
133
2020
Bat, CoV, HKU5-CoV, MERS, MERS spike receptor, MERS-CoV, MERS-CoV receptor DPP4, Middle East respiratory syndrome (MERS), PDF2180 chimera, Trypsin, Ugandan bat, Vero, bat, bat CoVs, bat group 2c CoV, bats, coronavirus, coronaviruses, exogenous trypsin, human, human cells, human gut cells, human lung cells, humans, severe, severe acute respiratory syndrome (SARS)-like, spike, spike protein
Author NameAffiliation
Vineet D MenacheryUniversity of Texas Medical Branch
Vineet D MenacheryUniversity of North Carolina at Chapel Hill
Boyd L YountUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Lisa E GralinskiUniversity of North Carolina at Chapel Hill
Rachel L GrahamUniversity of North Carolina at Chapel Hill
Lingshu WangVaccine Research Center, National Institute of Allergy and Infectious Diseases
Scott H Randelland Marsico Lung Institute/Cystic Fibrosis Center, University of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina School of Medicine
Ralph S BaricUniversity of North Carolina at Chapel Hill
Ralph S BaricUniversity of North Carolina School of Medicine
  • 1 - 12

Datasets

Release 1.2